Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B

J Gastroenterol Hepatol. 2014;29(7):1485-93. doi: 10.1111/jgh.12567.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives*
  • Adolescent
  • Adult
  • Aged
  • Antiviral Agents / administration & dosage*
  • Drug Resistance, Viral
  • Drug Therapy, Combination
  • Female
  • Hepatitis B e Antigens / immunology*
  • Hepatitis B e Antigens / metabolism
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / immunology*
  • Hepatitis B, Chronic / virology
  • Humans
  • Lamivudine / administration & dosage*
  • Male
  • Middle Aged
  • Organophosphonates / administration & dosage*
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Antiviral Agents
  • Hepatitis B e Antigens
  • Organophosphonates
  • Lamivudine
  • adefovir
  • Adenine